Is the new bivalent COVID-19 vaccine the booster we've been waiting for?
In a recent study published in The Lancet Respiratory Medicine, researchers evaluated the efficacy of a bivalent recombinant protein vaccine for coronavirus disease 2019 (COVID-19). Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were initially developed using the spike sequence from the ancestral strain, which is less effective against emerging variants of concern (VOCs). Therefore, updated vaccines have been […]
Continue reading »